Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01024296 · ClinicalTrials.gov registry record · NA

Efficacy Study to Evaluate Laparoscopic Fascial Closure Device

A NA study of Hernia, Abdominal, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
4
Enrollment target
1
Study location

NCT01024296 is a NA study of Hernia, Abdominal that has completed, run by Stanford University. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01024296, a NA study of Hernia, Abdominal, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

During any minimally invasive surgery case, 5-25mm size incisions need to be made to gain access to the abdomen. One of the most difficult, time-consuming, and sometimes unreliable parts of the case is closing these incisions, especially in obese patients. This is mainly because these incisions are very small and the layer that needs to be closed (fascia) rests deep underneath the skin and fat tissue of the abdominal wall. Two of the investigators (CM and BS) have developed at Stanford an instrument that allows for an easier and more reliable closure of these wounds. The purpose of this study is to test this instrument in the closure of laparoscopic wounds in obese patients undergoing laparoscopic gastric bypass surgery.

Conditions Studied

Interventions

  • DEVICE Port Close

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2009-07
Est. Completion 2010-03
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT01024296

The ClinicalTrials.gov registry entry for NCT01024296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hernia, Abdominal appearing as the primary indexed condition, and to 1 intervention - of which Port Close is the first listed.

NCT01024296 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01024296 about?

NCT01024296 is a clinical study titled "Efficacy Study to Evaluate Laparoscopic Fascial Closure Device". During any minimally invasive surgery case, 5-25mm size incisions need to be made to gain access to the abdomen. One of the most difficult, time-consuming, and sometimes unreliable parts of the case is closing these incisions, especially in obese patients. This is mainly because these incisions are ...

What is the current status of trial NCT01024296?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2009-07. Estimated completion is 2010-03.

What conditions does trial NCT01024296 study?

This clinical trial studies the following conditions: Hernia, Abdominal.

What interventions are being tested in trial NCT01024296?

The interventions under investigation include: Port Close (DEVICE).

Who is sponsoring clinical trial NCT01024296?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01024296 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hernia, Abdominal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.